In research published in Arthritis & Rheumatology, investigators developed and validated a tool called PRESTO that identifies patients with psoriasis who face an elevated risk for developing psoriatic arthritis and may therefore benefit from preventive therapies.
Awakn Life Sciences Announces Closing of Tranche of Private Placement and Warrant Extension | Psychedelic Invest
Toronto, Ontario–(Newsfile Corp. – July 31, 2024) – Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn” or the “Company”) a clinical-stage biotechnology
July 31, 2024